References
- Block M, Jacobsen L O, Bethard W F. Preleukemic acute human leukemia. JAMA 1953; 152: 1018–1028
- Rheingold J J, Kaufman R, Adelson E, Lear A. Smoldering acute leukemia. N Engl J Med 1963; 268: 812–815
- List A F, Doll D F. The myelodysplastic syndromes. Wintrobe's Clinical Hematology, 10th edn, G R Foerster, L J Lukens, F Paraskevas, J P Greer, G M Rodgers. Williams and Wilkins, Baltimore, MD 1999; 2320–2333
- Aul C, Germing U, Gattermann N, Minning H. Increasing incidence of myelodysplastic syndromes: real or fictitious?. Leuk Res 1998; 22: 93–100
- San Miguel J F, Sanz G F, Vallespi T, del Canizo M C, Sanz M A. Myelodysplastic syndromes. Crit Rev Oncol Hematol 1996; 23: 57
- Ahmad Y H, Kiehl R, Papac R J. Myelodysplasia: the clinical spectrum of 051 patients. Cancer 1995; 76: 869–874
- Aul C, Gattermann N, Schneider W. Age-related incidence and other epidemiologic aspects of myelodysplastic syndromes. Br J Haematol 1992; 82: 358
- Bennett M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Granlick H R, et al. Proposals for the classification of MDS. Br J Haematol 1982; 51: 189
- Davis J W, Weiss N S, Armstrong B K. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1987; 78: 91–94
- Bookman M A, Longo D L, Young R C. Late complications of curative treatment in Hodgkin's disease. JAMA 1988; 260: 680–683
- Weinsdorf D J, Oken M M, Johnson G J, Rydell R E. Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukemia. Br J Haematol 1983; 55: 691–700
- Raz I, Shinar E, Polliack A. Pancytopenia with hypercellular bone marrow-a possible paraneoplastic syndrome in carcinoma of the lung: a report of three cases. Am J Hematol 1984; 16: 403–408
- Sans-Sabrafen J, Buxo-Costa J, Woessner S, Florensa L, Besses C, Malats N, et al. Myelodysplastic syndromes and malignant solid tumors: analysis of 21 cases. Am J Hematol 1992; 41: 1–4
- Sans-Sabrafen J, Woessner S, Besses C, Lafuente R, Florensa L, Buxo J. Association of chronic myelomonocytic leukemia and carcinoma: a possible paraneoplastic myelodysplasia. Am J Hematol 1986; 22: 109–110
- Trichopoulos D. Medical Statistics: Principles and Basic Methods of Biomedical Statistics. Parisianos Scientific edns (Greek), Athens 1974; 63–81
- Breslow N E, Day N E. Statistical Methods in Cancer Research, Vol. I. The Analysis of Case-Control Studies. International Agency for Research on Cancer, IARC Scientific Publications, LyonFrance 1980, no. 32
- Juneja S K, Imbert M, Jouault H, Scoazec J Y, Sigaux F, Sultan C. Hematological features of primary myelodysplastic syndromes (PMDS) at initial presentation: a study of 118 cases. J Clin Pathol 1983; 36: 1129–1135
- Copplestone J A, Mufti G J, Hamblin T J, Oscier D G. Immunological abnormalities in myelodysplastic syndromes. Coexistent lymphoid or plasma cell neoplasms: a report of 20 cases unrelated to chemotherapy. Br J Hematol 1986; 63: 149–159
- Chan D W, Sell S. Tumor markers. Tietz Textbook of Clinical Chemistry, 3rd edn, C A Burtis, E R Ashwood. WB Saunders, Philadelphia 1999; 722–739
- Harada H, Kongo T, Ogawa S, Tamura T, Kitagawa M, Tanaka N, et al. Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia: a possible mechanism of tumor suppressor inactivation. Oncogene 1994; 9: 3313–3320